Availability of inhaled insulin promotes greater perceived acceptance of insulin therapy in patients with type 2 diabetes

被引：79
|
作者：
Freemantle, N
Blonde, L
Duhot, D
Hompesch, M
Eggertsen, R
Hobbs, FDR
Martinez, L
Ross, S
Bolinder, B
Stridde, E
机构：
[1] Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England
[2] Alton Ochsner Med Fdn & Ochsner Clin, New Orleans, LA 70121 USA
[3] Soc Francaise Med Gen, Issy Les Moulineaux, France
[4] Profil Inst Clin Res, Chula Vista, CA USA
[5] Gothenburg Univ, Dept Primary Hlth Care, Gothenburg, Sweden
[6] Univ Calgary, Fac Med, Calgary, AB T2N 1N4, Canada
[7] Aventis Pharma, Bridgewater, NJ USA
[8] Pfizer, Karlsruhe, Germany
来源：
DIABETES CARE | 2005年 / 28卷 / 02期
关键词：
D O I：
10.2337/diacare.28.2.427
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：427 / 428
页数：2
相关论文
共 50 条
  • [1] Inhaled insulin leads to a greater potential acceptance of insulin therapy in patients with uncontrolled Type 2 diabetes
    Freemantle, N
    Blonde, L
    Bolinder, B
    Hompesch, M
    Duhot, D
    Eggertsen, R
    Hobbs, EDR
    Martinez, L
    Ross, SA
    Stridde, E
    DIABETOLOGIA, 2004, 47 : A310 - A311
  • [2] Inhaled insulin (Exubera®) leads to a greater potential acceptance of insulin therapy in patients with uncontrolled type 2 diabetes
    Freemantle, N
    Blonde, L
    Bolinder, B
    Hompesch, M
    Duhot, D
    Eggertsen, R
    Hobbs, FDR
    Martinez, L
    Ross, S
    Stridde, E
    DIABETES, 2004, 53 : A466 - A466
  • [3] The availability of inhaled human insulin may lead to a greater acceptance of insulin therapy in European type 2 diabetes patients failing on diet and/or oral agent therapy
    Freemantle, N.
    Blonde, L.
    Hobbs, F. D. R.
    Kvasz, M.
    Marchant, N.
    Ross, S. A.
    DIABETOLOGIA, 2006, 49 : 618 - 619
  • [4] The availability of inhaled insulin leads to improved health outcomes in patients with uncontrolled Type 2 diabetes
    Blonde, L
    Freemantle, N
    Ross, SA
    Bolinder, B
    Gerber, RA
    DIABETOLOGIA, 2004, 47 : A310 - A310
  • [5] Initiation of Prandial Insulin Therapy with AIR Inhaled Insulin or Insulin Lispro in Patients with Type 2 Diabetes: A Randomized Noninferiority Trial
    Gross, Jorge L.
    Nakano, Masako
    Colon-Vega, Gildred
    Ortiz-Carasquillo, Ramon
    Ferguson, Jeffrey A.
    Althouse, Sandra
    Tobian, Janet A.
    Berclaz, Pierre-Yves
    Milicevic, Zvonko
    DIABETES TECHNOLOGY & THERAPEUTICS, 2009, 11 : S27 - S34
  • [6] Inhaled insulin: recent advances in the therapy of Type 1 and 2 diabetes
    Quattrin, T
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (12) : 2597 - 2604
  • [7] Inhaled insulin plus insulin glargine versus biaspart insulin for type 2 diabetes
    不详
    AFRICAN JOURNAL OF DIABETES MEDICINE, 2010, 18 (02): : 18 - 18
  • [8] Inhaled human insulin treatment in patients with type 2 diabetes mellitus
    Cefalu, WT
    Skyler, JS
    Kourides, IA
    Landschulz, WH
    Balagtas, CC
    Cheng, SL
    Gelfand, RA
    ANNALS OF INTERNAL MEDICINE, 2001, 134 (03) : 203 - 207
  • [9] Inhaled insulin superior to rosiglitazone in patients with uncontrolled type 2 diabetes
    不详
    FORMULARY, 2003, 38 (07) : 408 - 408
  • [10] Restaging insulin therapy for patients with type 2 diabetes
    Garber, A. J.
    DIABETES OBESITY & METABOLISM, 2009, 11 : 1 - 5
12345